Coprelotamab Antibody
Coprelotamab (GB-221) is a monoclonal IgG1 kappa antibody targeting EGFR2, commonly expressed in CHO DG44 cells. It is utilized in oncology research for investigating EGFR2 signaling pathways in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
Target
HER
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
6.11 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0024905-01 200 µL
FITC-Linked Polyclonal Antibody to Suppressor Of Variegation 4-20 Homolog 2 (SUV420H2)
Sign In for Pricing
View Details TRV-0024905-02 1 mL
FITC-Linked Polyclonal Antibody to Suppressor Of Variegation 4-20 Homolog 2 (SUV420H2)
Sign In for Pricing
View Details 
MBS1084420-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus UPF0297 protein NWMN_1518 (NWMN_1518)
Sign In for Pricing
View Details MBS1084420-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus UPF0297 protein NWMN_1518 (NWMN_1518)
Sign In for Pricing
View Details MBS1084420-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus UPF0297 protein NWMN_1518 (NWMN_1518)
Sign In for Pricing
View Details MBS1084420-04 0.1 mg (Yeast)
Recombinant Staphylococcus aureus UPF0297 protein NWMN_1518 (NWMN_1518)
Sign In for Pricing
View Details